重症急性胰腺炎(SAP)是常见急腹症及危重症之一,它不仅是胰腺的局部炎症病变,而且是涉及多个脏器的全身性疾病,发病急、变化快、并发症多、病死率极高。随着现代监护、诊疗手段的不断发展及对SAP病理生理过程研究的深入,其治疗方针发展为现阶段“个体化”治疗方针[1]。本文现介绍近年来SAP的治疗现状,综述如下。 Severe acute pancreatitis (SAP) is one of the common acute abdomen and critically ill patients. It is not only a local inflammation of the pancreas, but also a systemic disease involving multiple organs. It is characterized by acute onset, rapid change, multiple complications and death Very high rate. With the development of modern supervision, the continuous development of medical treatment and the further study of the pathophysiological process of SAP, the treatment guidelines have been developed into the current “individualized” treatment guidelines [1]. This article describes the status of SAP treatment in recent years, summarized as follows.